Cellceutix Corp (OTCQB:CTIX)

Data as of Oct 23
 +0.19 / +6.33%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Cellceutix Corp. is a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. It flagship compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. The company was founded by Krishna Kumar Menon and Leo Ehrlich in June 2007 and is headquartered in Beverly, MA.

Contact Information

Cellceutix Corp.
100 Cummings Center
Beverly Massachusetts 01915
P:(978) 236-8717
Investor Relations:



Individual stakeholders31.50%
Mutual fund holders--
Other institutional--

Top Executives

Leo EhrlichChairman, CEO, CFO, Secretary, Director & CAO
Krishna Kumar MenonPresident, Director & Chief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.